Orally Assimilable Or Injectable Composition Patents (Class 424/643)
-
Patent number: 11958872Abstract: The present invention relates to a novel zinc complex compound having zinc as a center metal and comprising citric acid and arginine as a ligand.Type: GrantFiled: September 20, 2019Date of Patent: April 16, 2024Inventor: Lae Ok Park
-
Patent number: 11730835Abstract: A method for treating melanoma or preventing the development of melanoma comprising administration of a composition comprising 64Zne(Asp)2 in a therapeutically effective amount. Such administration may be via injection such as intratumoral and/or intravenous injection and may be once a day or more than once a day. A composition for the treatment of or prevention of melanoma comprising 64Zne(Asp)2 in a therapeutically effective amount. The composition may be a liquid suitable for injection.Type: GrantFiled: October 19, 2022Date of Patent: August 22, 2023Assignee: Vector Vitale IP LLCInventors: Peter Novak, Maxim V. Temnikov, Oleksandr Balakin
-
Patent number: 11684559Abstract: The invention provides the use of at least one alkyl-phthalide or a plant extract comprising mainly said alkyl-phthalide for the topical cosmetic treatment of the skin and of the scalp, in particular an anti-dandruff treatment. According to the invention, a CO2 supercritical extract of Apium graveolens seeds consisting mainly of sedanenolide may be used.Type: GrantFiled: October 7, 2021Date of Patent: June 27, 2023Assignee: SedermaInventors: Olga Gracioso, Caroline Ringenbach, Thibault Marchand, Philippe Mondon, Nicolas Barriere
-
Patent number: 11596650Abstract: A method of preventing or treating type 2 diabetes comprising administering a therapeutically effective amount of 64Zn-enriched zinc.Type: GrantFiled: December 20, 2019Date of Patent: March 7, 2023Assignee: Vector Vitale IP LLCInventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin
-
Patent number: 11590190Abstract: Various embodiments of the invention relate to compositions comprising vitamins, minerals and trace elements, antioxidants, amino acids, probiotics, and other components and methods for using such compositions to treat or prevent diseases associated with oxidative stress, including cardiovascular disease.Type: GrantFiled: April 19, 2019Date of Patent: February 28, 2023Assignee: Sweet Wellness ABInventor: Per-Arne Öckerman
-
Patent number: 11484610Abstract: A method for treating melanoma or preventing the development of melanoma comprising administration of a composition comprising 64Zne(Asp)2 in a therapeutically effective amount. Such administration may be via injection such as intratumoral and/or intravenous injection and may be once a day or more than once a day. A composition for the treatment of or prevention of melanoma comprising 64Zne(Asp)2 in a therapeutically effective amount. The composition may be a liquid suitable for injection.Type: GrantFiled: November 22, 2019Date of Patent: November 1, 2022Assignee: VECTOR VITALE IP LLCInventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin
-
Patent number: 11439676Abstract: Embodiments of a method and supplement for preventing and/or treating gastrointestinal distress, including ulcer conditions, in animals such as humans are disclosed. The supplement is in a gel or other form and comprises mastic gum and an emulsifying agent such as lecithin. The supplement may also comprise B vitamins, one or more prebiotics or probiotics, and one or more minerals as well as, pH buffers and flavoring. A disclosed method of preventing and/or treating gastrointestinal distress comprises orally dosing an animal such as a human with the supplement at least once daily.Type: GrantFiled: September 1, 2020Date of Patent: September 13, 2022Assignee: KAECO Group, Inc.Inventors: Kelly Terry, Leon Kratochvil, James Harless, Tom Kratochvil
-
Patent number: 11166897Abstract: The invention provides a method for the topical non therapeutical cosmetic treatment of the scalp comprising applying to the scalp an effective amount of at least one alkyl-phthalide or a plant extract comprising mainly said alkyl-phthalide. In particular, the treatment is an anti-dandruff treatment. According to the invention, a CO2 supercritical extract of Apium graveolens seeds consisting mainly of sedanenolide may be used.Type: GrantFiled: May 16, 2019Date of Patent: November 9, 2021Assignee: SedermaInventors: Olga Gracioso, Caroline Ringenbach, Thibault Marchand, Philippe Mondon, Nicolas Barriere
-
Patent number: 10517322Abstract: Provided herein are formulations and methods helping individuals enhance cognitive function, facilitate memory processing, induce and maintain sleep, stabilize mood, reduce symptoms of stress and anxiety, facilitate energy production, improve mental and emotional health, or support long-term brain health.Type: GrantFiled: March 18, 2019Date of Patent: December 31, 2019Assignee: Life Kitchen, LLCInventor: James Wukjae Lee
-
Patent number: 10376601Abstract: An in-vivo intravascular blood replacing liquid of the present invention is injected into a blood vessel to replace blood at an intravascular portion to be inspected therewith in making an in-vivo intravascular inspection. The blood replacing liquid comprises an aqueous medium unharmful for a living body and a gelling property imparting substance, unharmful for the living body, which is added to the aqueous medium to impart a gelling property to the blood replacing liquid. The blood replacing liquid has a viscosity of not more than 3 mPa·s when the blood replacing liquid is injected into the blood vessel.Type: GrantFiled: September 27, 2016Date of Patent: August 13, 2019Assignee: TERUMO KABUSHIKI KAISHAInventors: Koji Nakamura, Isao Mori, Masanori Tokida
-
Publication number: 20150139938Abstract: The present invention provides methods of promoting arteriogenesis in a subject. Embodiments include methods comprising: administering an effective dose of tocotrienol to the subject; causing an increase in Tissue Inhibitor of Metalloproteinase Metallopeptidase Inhibitor 1 (TIMP1) in vessels of cerebrovascular collateral circulation in the subject; attenuating the activity of Matrix Metalloproteinase-2 (MMP2); thereby promoting arteriogenesis.Type: ApplicationFiled: June 7, 2013Publication date: May 21, 2015Applicant: Ohio State Innovation FoundationInventors: Chandan Sen, Cameron Rink, Sashwati Roy, Greg Christoforidis
-
Publication number: 20150140121Abstract: Compositions and methods for modifying the composition of tight junction complexes and/or improving epithelial barrier function are disclosed.Type: ApplicationFiled: June 10, 2013Publication date: May 21, 2015Inventors: James M. Mullin, Jonathan M. Raines
-
Patent number: 8992999Abstract: A composition for preventing or reducing harmful effects of protozoal infection is provided, comprising in one embodiment a yeast cell wall and a preparation derived from oregano. The composition may further include a mineral nutrient selected from selenium and/or zinc. The composition may also include a preparation derived from Yucca. Efficacy of the composition is shown against a variety of protozoal organisms.Type: GrantFiled: July 21, 2004Date of Patent: March 31, 2015Assignee: Alltech, Inc.Inventors: Cepta Duffy, Aidan Joseph Connolly
-
Patent number: 8987244Abstract: Methods are provided for reducing copper values for, by way of example, treating, preventing or ameliorating tissue damage such as, for example, tissue damage that may be caused by (i) disorders of the heart muscle (for example, cardiomyopathy or myocarditis) such as idiopathic cardiomyopathy, metabolic cardiomyopathy which includes diabetic cardiomyopathy, alcoholic cardiomyopathy, drug-induced cardiomyopathy, ischemic cardiomyopathy, and hypertensive cardiomyopathy, (ii) atheromatous disorders of the major blood vessels (macrovascular disease) such as the aorta, the coronary arteries, the carotid arteries, the cerebrovascular arteries, the renal arteries, the iliac arteries, the femoral arteries, and the popliteal arteries, (iii) drug induced, and metabolic (including hypertensive and/or diabetic disorders of small blood vessels (microvascular disease) such as the retinal arterioles, the glomerular arterioles, the vasa nervorum, cardiac arterioles, and associated capillary beds of the eye, the kidney, the hType: GrantFiled: September 18, 2013Date of Patent: March 24, 2015Assignee: PhilERA New Zealand LimitedInventors: Garth J. S. Cooper, John R. Baker
-
Publication number: 20150056297Abstract: A dietary supplement in capsule or tablet form includes a source of zinc in an amount equivalent to 6 mg to 40 mg of zinc chloride; optionally a source of chromium in an amount equivalent to 100 micrograms to 1000 micrograms of chromium picolinate; optionally from 4 micrograms to 100 micrograms of Vitamin B12; optionally an extract or powdered form of American Ginseng in an amount that provides from 20 mg to 200 mg of ginsenoside(s), or 20 mg to 200 mg of isolated or synthesized ginsenoside(s); optionally an oil, extract or powdered form of cinnamon bark in an amount that provides 1000 mg to 5000 mg of methylhydroxychalcone polymer; optionally 2 mg to 50 mg lutein; and optionally green tea extract in an amount that provides from 200 mg to 4000 mg of epigallocatechin gallate or 200 mg to 4000 mg of isolated or synthesized epigallocatechin gallate.Type: ApplicationFiled: August 18, 2014Publication date: February 26, 2015Inventor: Charles H. Liu
-
Publication number: 20150056298Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.Type: ApplicationFiled: October 31, 2014Publication date: February 26, 2015Inventors: Bobak Robert Azamian, Scott Bradley Vafai
-
Patent number: 8962696Abstract: The invention provides a method and a composition for enhancing the dissolution and bioavailable properties of propofol (2, 6 diisopropyl phenol) for use as an intravenously administered anesthetic in mammals. The method produces a self-microemulsifyable emulsion base composition that is utilized in the production of a water-based microemulsion preparation. In a preferred two (2) component base composition, the base composition consists of: a surfactant, containing polyethylene glycol; and liquid propofol. The microemulsion is prepared by mixing the base composition with a carrier liquid, which results in the formation of a microemulsion containing concentrations of propofol of up to about 4% by weight of propofol to the volume of the microemulsion. In a four (4) component base composition, the base composition consists of: a surfactant, containing polyethylene glycol; liquid propofol; a water-immiscible solvent; and ethanol.Type: GrantFiled: January 11, 2013Date of Patent: February 24, 2015Assignee: Medos, Inc.Inventors: Steven B. Harris, Nick J. Huang
-
Publication number: 20150050261Abstract: The present invention relates to dietary and nutritional supplements comprising various vitamins, minerals and nutrients, including an omega-3 fatty acid of plant-based origin and a folate derivative.Type: ApplicationFiled: August 15, 2014Publication date: February 19, 2015Inventors: Chris G. Evenstad, Kelly M. Heimerl, Mike J. McBride, Ronnie Ortiz, Carrol J. Rhead, Sami Yusuf, Michelle B. Zachman
-
Publication number: 20150030698Abstract: An oral product that includes an amino acid nitric oxide precursor and a compound capable of providing zinc ions. The product can be formulated as a powder and mixed with a liquid in preparation for consumption by a person. The powdered formulation may be mixed with water followed by a brief but necessary allotment of time for the powdered formulation to completely react in the water. The resulting beverage may then be consumed by a person or user to facilitate production of nitric oxide and creatine-phosphate that is usable by the person, especially to help recover and rejuvenate the person after physical exertion and reduce or relieve muscle soreness.Type: ApplicationFiled: July 28, 2014Publication date: January 29, 2015Inventor: R. Charles Thompson
-
Publication number: 20150024067Abstract: A treatment and prevention formulation for canker sores of the oral cavity including an aqueous alkaline solution having at least three B vitamins and zinc (provided as Zn (II) EDTA alkali metal salt) mixed therein and administered to a target area by a spray container. The vitamins are B6, B9 and B12, but may include other vitamins as well. The formulation is totally non-toxic in chemical nature and non-offensive in odor to others, so it can be used anywhere and at any time and can be swallowed after use.Type: ApplicationFiled: October 7, 2013Publication date: January 22, 2015Inventors: Plato Chun-Chih Lee, Arthur Joseph Dietrich
-
Patent number: 8916150Abstract: Methods and compositions are provided for increasing responsiveness to therapeutic metalloproteases including increasing and/or maximizing responsiveness and preventing botulinum and tetanus toxin resistance due to a functional deficiency of zinc. Also provided are methods for zinc replacement or supplement in lacking individuals comprising the administration of a zinc supplement for a loading period and/or administration of a phytase supplement together with the zinc supplement. Also provided are methods for standardization of botulinum toxin potency assays that provide for greater certainty and margins of safety in the use of products from different manufacturers.Type: GrantFiled: October 30, 2013Date of Patent: December 23, 2014Assignee: CNSS IP Holdings, Inc.Inventor: Charles N. S. Soparkar
-
Publication number: 20140342018Abstract: The present invention provides formulas of elemental compositions encompassing acetate salts of calcium, magnesium and zinc along with vitamin D3. The acetate salts could be extracted from natural sources such as pearls, coral, and oyster or compounded using synthetic materials. The dosage and ratio of calcium to magnesium was estimated using in vitro and in vivo estimations. The dosage for promoting bone health and alleviation of osteoporosis is about a quarter to a third of the conventional dose.Type: ApplicationFiled: April 1, 2014Publication date: November 20, 2014Applicant: Sinoveda Canada Inc.Inventor: Yun Kau TAM
-
Patent number: 8883221Abstract: Micronutrient combination product, wherein the micronutrient combination product comprises zeaxanthin, lutein, zinc and copper.Type: GrantFiled: December 17, 2004Date of Patent: November 11, 2014Assignee: Bausch & Lomb IncorporatedInventors: Guenter Bellmann, Gudrun Claus-Herz
-
Publication number: 20140308369Abstract: An orally administered dietary product intended to reduce an obese person's visceral fat during the pre-operative phase prior to bariatric surgery, the product includes in particular a mixture of: a whey hydrolysate having a molecular weight of between 200 and 10,000 daltons, an isolate and/or a concentrate of whey, and calcium caseinate.Type: ApplicationFiled: October 25, 2012Publication date: October 16, 2014Applicant: INTERNATIONAL NUTRITION RESEARCH COMPANYInventor: Claude Vincent
-
Publication number: 20140302169Abstract: A method wherein subjects having or at risk for having hyperopia, presbyopia or astigmatism are administered a composition having an effective amount of ocular antioxidants, including specifically macular pigments, to prevent, treat, or delay the onset of age-related macular degeneration (AMD).Type: ApplicationFiled: June 18, 2014Publication date: October 9, 2014Inventor: Richard Roberts
-
Patent number: 8840933Abstract: The invention provides methods and kits for treatment of pain or inflammation. In one embodiment, the kit comprises a biomembrane sealing agent, such as PEG, and a bioactive agent, such as a magnesium compound. The biomembrane sealing agent and/or the bioactive agent an intravenous administration, an intramuscular administration, an intrathecal administration, a subcutaneous administration, an epidural administration, a parenteral administration, an intra-articular administration, a direct application onto or adjacent to a site of the pathological condition, and any combinations thereof. Alternatively, the biomembrane sealing agent and/or the bioactive agent may be delivered from a pump or an implant.Type: GrantFiled: May 3, 2006Date of Patent: September 23, 2014Assignee: Warsaw Orthopedic, Inc.Inventors: Josee Roy, William F. McKay, Jeffrey C Marx
-
Publication number: 20140255512Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.Type: ApplicationFiled: May 23, 2014Publication date: September 11, 2014Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.Inventors: Franco GAETANI, Ashraf VIRMANI
-
Publication number: 20140242161Abstract: The present invention relates to soft gelatin capsules characterized in that the shell includes a cyclodextrin and in that the filling material contains a liposoluble drug capable of forming a complex with said cyclodextrin for improving the solubility of the active ingredient upon disintegration of the soft gelatin capsule.Type: ApplicationFiled: April 7, 2014Publication date: August 28, 2014Inventors: Giorgio ZOPPETTI, Maurizio MARCHIORRI
-
Publication number: 20140227371Abstract: The present invention relates to edible compositions for the maintenance of normal liver function comprising zinc, 1-deoxynojirimycinand ?-lipoic acid.Type: ApplicationFiled: May 31, 2012Publication date: August 14, 2014Inventors: Alan David Heath, Dawn Jennae Mazzatti, Charlotte Mary Walden
-
Publication number: 20140212508Abstract: A Copper/Zinc superoxide dismutase (Cu/Zn SOD) composition comprising a therapeutically effective amount of ionic mineral(s) in a ligand complex and a pharmaceutically acceptable carrier for the neutralization of superoxide produced trauma and/or stress-related conditions including, but not limited to, conditions such as myotrophic lateral sclerosis (ALS). The composition may also include other supporting adjutants such as bioavailable magnesium, manganese, selenium and other minerals that can support the nervous system and other vitamins and glutathione and other nutrients. Botanical extracts, urea, other supplements helpful for protection and re-enforcement of the immune system are discussed.Type: ApplicationFiled: April 3, 2014Publication date: July 31, 2014Inventor: John Wayne Kennedy
-
Publication number: 20140199414Abstract: The present invention relates to a method of treatment and/or prevention of cardiovascular disease, rheumatoid arthritis, skin cancer, premenstrual syndrome, diabetes and transdermal transport enhancement. The method comprises the administration of a therapeutically effective amount of krill and/or marine oil to a patient. The present invention also relates to a composition for the treatment and/or prevention of these diseases.Type: ApplicationFiled: January 10, 2014Publication date: July 17, 2014Applicant: Neptune Technologies & Bioressources Inc.Inventor: Tina Sampalis
-
Patent number: 8778410Abstract: The present invention provides an oral or enteral composition incorporating not only BCAA but other nutrients to be conducive to comprehensive recovery from fatigue, and improvement in total physical condition. The oral or enteral composition is formulated as a composite of a branched-chain amino acid, coenzyme Q10, L-carnitine, a citric acid, and zinc.Type: GrantFiled: February 19, 2009Date of Patent: July 15, 2014Assignees: Earnest Medicine Co., Ltd., Otsuka Pharmaceutical Factory, Inc.Inventors: Takashi Higashiguchi, Takako Hatakeyama
-
Patent number: 8778311Abstract: The present invention relates to an oral composition comprising, in an orally acceptable carrier, from about 0.1% to about 5% zinc oxide; and from about 0.1% to about 5% of a source of carbonate ions selected from alkali metal and ammonium carbonates and bicarbonates. The molar ratio of carbonate ion to zinc ion is from about 0.05:1 to about 1:1. The composition has good antiplaque efficacy and taste. Preferred compositions are toothpastes.Type: GrantFiled: March 20, 2007Date of Patent: July 15, 2014Assignee: The Procter & Gamble CompanyInventors: Meinrad Regner, Maurice Joseph Prendergast, Owen Thurlby
-
Publication number: 20140161907Abstract: The present invention relates to compositions that may be swallowable, chewable or dissolvable, comprising various vitamins and minerals, and in a specific embodiment comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D3, vitamin E, iron, magnesium and zinc, and methods for using these compositions for nutritional supplementation in subjects undergoing physiologically stressful events, such as, for example and without limitation, pregnancy, lactation or any disease state.Type: ApplicationFiled: February 18, 2014Publication date: June 12, 2014Inventors: John A. Giordano, Charles J. Balzer
-
Publication number: 20140161890Abstract: A magnetic oxide-quantum dot nanocomposite has at least one magnetic oxide nanoparticle coated with a silica (SiO2) shell and terminated with at least one thiol group (—SH) and at least one CdSe/ZnS quantum dot linked with the at least one SiO2-coated magnetic oxide nanoparticle via the at least one thiol group. The at least one magnetic oxide nanoparticle can be an iron oxide (Fe3O4) nanoparticle. A method of cancer treatment using the magnetic oxide-quantum dot nanocomposites, includes the steps of delivering a plurality of nmagnetic oxide-quantum dot nanocomposites to a cancer cell, and subjecting the cancer cell with the plurality of magnetic oxide-quantum dot nanocomposites to a radio frequency induction for a period of time effective to cause the cancer cell to die.Type: ApplicationFiled: February 17, 2014Publication date: June 12, 2014Applicant: Board of Trustees of the University of ArkansasInventors: Alexandru S. Biris, Yang Xu, Daoyuan Wang
-
Publication number: 20140154339Abstract: The present invention relates to the use of pharmaceutically acceptable zinc salts, in particular, zinc chloride and zinc acetate, alone or optionally, in combinations with one or more of a protein pump inhibitor (PPI), H2 blocker, anti-H. pylori antibiotic/antimicrobial, cytoprotective agent or a combination agent as otherwise described herein for providing fast action with optional long duration effect in reducing gastric acid secretion, including acid secretion in the fundus (by inhibiting vacuolar H+-ATPase or H+/K+-ATPase) and upper body region of the stomach (by inhibiting H+/K+-ATPase), thus raising the pH of gastric juices in rapid fashion and decreasing the duration of stomach acid release during a secretagogue phase. This method is also directed to treating conditions including gastroesophageal reflux disease (GERD), non-erosive reflux disease (NERD), Zollinger-Ellison syndrome (ZE disease), ulcer disease, and gastric cancer, as well as preventing or reducing the likelihood of ulcer disease.Type: ApplicationFiled: May 22, 2013Publication date: June 5, 2014Inventors: John P. Geibel, Phillipp Kirchhoff
-
Publication number: 20140147515Abstract: A composition for preventing or reducing harmful effects of protozoal infection is provided, comprising in one embodiment a yeast cell wall and a preparation derived from oregano. The composition may further include a mineral nutrient selected from selenium and/or zinc. The composition may also include a preparation derived from Yucca. Efficacy of the composition is shown against a variety of protozoal organisms.Type: ApplicationFiled: July 21, 2004Publication date: May 29, 2014Applicant: Alltech, Inc.Inventors: Cepta Duffy, Aidan Joseph Connolly
-
Publication number: 20140113004Abstract: Methods of inhibiting Barrett's esophagus and/or adenocarcinoma in a subject are provided. In a particular embodiment, the method comprises administering at least one composition comprising at least one zinc compound and at least one pharmaceutically acceptable carrier to the esophagus of the subject. The zinc may be a pharmaceutically acceptable salt of zinc, such as zinc gluconate. The zinc may be administered, for example, orally, topically, or by an implantable medical device. In a particular embodiment, the methods further comprise administering at least one analgesic, anesthetic, or other therapeutic agent or therapy for the treatment of Barrett's esophagus. The method may further comprise monitoring the progression of Barrett's esophagus in the subject.Type: ApplicationFiled: May 7, 2012Publication date: April 24, 2014Applicants: Monk Street Partners LLC, Lankenau Institute for Medical ResearchInventors: James M. Mullin, Jonathan Raines
-
Patent number: 8673362Abstract: The present invention relates to a composition and uses thereof for treatment of damaged tissue comprising at least one essential amino acid in L form and at least one essential lipid; wherein the composition is administered to a mammal suffering from severe tissue damage. The invention further relates to a composition and uses thereof comprising the mixture of one or more free L-amino acids in which the molar ratio of the free L-amino acids corresponds to the molar ratio of amino components in a mammalian tissue protein; and at least one essential lipid.Type: GrantFiled: October 24, 2011Date of Patent: March 18, 2014Assignee: Immunopath Profile, Inc.Inventor: Leonard S. Girsh
-
Patent number: 8658218Abstract: A composition for treating damaged tissue and promoting healthy tissue growth, healing and tissue regeneration, wherein the composition comprises an extracellular matrix compound, a surface-active lipid, one or more enantiomericaily pure L-amino acids or glycine, a hydrophilic surfactant with a high HLB, as well as vitamins, minerals or trace elements. Not only does it maintain good health, but the components are non-intrusive, bio-safe, non-coalescent and can mimic normally occurring stem-cells within a body. When applied to diseased tissues, the subject compositions can stimulate, facilitate, and accelerate protein synthesis for the regeneration of diseased organs and tissues. The healing efficacy of these tissue components gives us further appreciation of the protective action of human tissue over and above and other than the immune protective system or perhaps an integral component part of the immune system.Type: GrantFiled: February 8, 2012Date of Patent: February 25, 2014Assignee: Immunopath Profile, Inc.Inventor: Leonard S. Girsh
-
Patent number: 8652495Abstract: Disclosed are oral care compositions, for example dentifrice compositions, comprising an oral care composition comprising an orally acceptable vehicle, metal oxide particles having an average particle size of no greater than a dentin tubule and at least one amino acid capable of chelating the metal oxide. The composition may comprise a polymeric adherent material for adhering the metal oxide particles in the dentin tubule. The metal oxide particles have a median particle size of 5 microns or less, and may comprise zinc oxide.Type: GrantFiled: March 31, 2010Date of Patent: February 18, 2014Assignee: Colgate-Palmolive CompanyInventors: Venda Porter, Andre Morgan, Michael Prencipe
-
Publication number: 20140044685Abstract: Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional compositions may provide for retention of lean body mass, which helps to avoid loss of independence and functionality, as well as to improve quality of life especially in the elderly at risk of sarcopenia and frailty. The nutritional compositions include ?-hydroxyisocaproic acid and citrulline. The composition may include other functional ingredients such as, but not limited to whey protein including whey protein micelles, prebiotic fibers, ?-keto-glutarate, eicosapentaenoic acid, L-carnitine, nucleotides, and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 18, 2012Publication date: February 13, 2014Applicant: NESTEC S.A.Inventors: Norman Alan Greenberg, Denis Breuille, Zamzam Kabiry (Fariba) Roughead, Doug Bolster, Jennifer Mager
-
Patent number: 8641776Abstract: This invention relates in one aspect to the treatment of a vascular vessel with a biomaterial. The biomaterial can be a remodelable material that strengthens and/or supports the vessel walls. Additionally the biomaterial can include a variety of naturally occurring or added bioactive agents and/or viable cellular populations.Type: GrantFiled: March 15, 2011Date of Patent: February 4, 2014Assignees: Cook Biotech Incorporated, Cook Medical Technologies LLCInventors: Brian C. Case, Michael C. Hiles, Jacob A. Flagle, F. Joseph Obermiller, Umesh H. Patel
-
Publication number: 20140030241Abstract: Nutritional compositions having dietary nucleotides, ?-3 fatty acids and citrulline are provided. The nutritional compositions may be formulated to improve T cell function, increase arginine availability in vivo, regulate myeloid-derived suppressor cells (“MDSC”), and decrease the risk and/or severity of infection after surgery or trauma. Methods of making, using and administering such nutritional compositions to individuals in need of same are also provided. Methods for modulating the affects of MDSC's are also provided.Type: ApplicationFiled: March 15, 2012Publication date: January 30, 2014Applicant: NESTEC S.A.Inventor: Norman Alan Greenberg
-
Publication number: 20140017337Abstract: Therapeutic methods includes several stages, including a modified fasting and low calorie stages, with low impact, moderate exercise, a sliming stage, and a maintenance stage. Nutritional therapeutics are also consumed during each phase, which support a plurality of metabolic and physiological functions.Type: ApplicationFiled: July 11, 2012Publication date: January 16, 2014Inventor: Paul Amoruso
-
Publication number: 20140017338Abstract: A composition, system and method for modifying an olfactory response to an odorant is disclosed. In some embodiments, the composition includes crystalline metal nanoparticles dispersed in an aqueous medium. The composition is applied to olfactory tissues using a suitable applicator or dispenser. The metal nanoparticles are believed to interact with a G-protein coupled to receptor located in the cilia to moderate (enhance or reduce) sensitivity or ability to smell particular odorants. In accordance with an embodiment of the invention, the composition includes one or more odorants.Type: ApplicationFiled: September 17, 2013Publication date: January 16, 2014Applicant: Auburn UniversityInventors: Vitaly J. Vodyanoy, Nilmini Viswaprakash, Ludmila Petrovna Globa, Edward E. Morrison
-
Publication number: 20130344167Abstract: The present invention relates to a galenic composition suitable for administration to a non-human animal, including at least the following three components: one or more active principles; an agent for accelerating delitescence; an agent for delaying delitescence, wherein the agent for accelerating delitescence an the agent for delaying delitescence are integrated in the composition so as to form a matrix with the controlled release of the active principle(s). The invention also relates to the uses of said compositions, as well as to a method for measuring the in vitro delitescence thereof.Type: ApplicationFiled: November 27, 2011Publication date: December 26, 2013Applicant: VETALIS SARLInventors: Laurent Chery, Jean-Pierre Wajda-Dubos
-
Publication number: 20130330411Abstract: An oral cyclosporin composition comprises minicapsules having a core containing a cyclosporin, especially cyclosporin A in a solubilised liquid form. The minicapsules have a release profile to release the pre-solubilised cyclosporin, at least in the colon. The composition may be used for treating a range of intestinal diseases [FIG. 10].Type: ApplicationFiled: July 15, 2013Publication date: December 12, 2013Inventor: Ivan Coulter
-
Publication number: 20130316017Abstract: Provided is a composition that is useful for treating acne, and which has been found to reduce and/or eliminate acne outbreaks or reduce the severity thereof. The composition includes mangosteen and curcumin. At least a portion of the mangosteen and curcumin can be provided in the form of extracts thereof. The composition can optionally include other components such as guggul, guggul extracts, thyme, thyme extracts, piperine, vitamin B5, vitamin B6, zinc, beta glucans, and green tea extracts. The composition can be provided as an oral administration unit such as a pill or capsule. Also provided is a method of treating acne by ingesting an effective amount of the composition described herein.Type: ApplicationFiled: May 24, 2013Publication date: November 28, 2013Inventor: Michael Hynes
-
Patent number: 8591884Abstract: Methods and compositions are provided for increasing responsiveness to therapeutic metalloproteases including increasing and/or maximizing responsiveness and preventing botulinum and tetanus toxin resistance due to a functional deficiency of zinc. Also provided are methods for zinc replacement or supplement in lacking individuals comprising the administration of a zinc supplement for a loading period and/or administration of a phytase supplement together with the zinc supplement. Also provided are methods for standardization of botulinum toxin potency assays that provide for greater certainty and margins of safety in the use of products from different manufacturers.Type: GrantFiled: June 23, 2010Date of Patent: November 26, 2013Assignee: CNSS IP Holdings, IncInventor: Charles N. S. Soparkar